(BAMG) Brookstone Growth Stock - Overview
Etf: Technology, Healthcare, Consumer, Financials, Industrials
| Risk 5d forecast | |
|---|---|
| Volatility | 22.2% |
| Relative Tail Risk | 6.39% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | -5.77 |
| Character TTM | |
|---|---|
| Beta | 1.021 |
| Beta Downside | 0.988 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.00% |
| CAGR/Max DD | 1.02 |
Description: BAMG Brookstone Growth Stock January 19, 2026
BAMG (Brookstone Growth Stock ETF) is an actively managed U.S. equity ETF that seeks companies with strong earnings-growth prospects over the next several years, allocating at least 80% of its net assets (plus any investment-purpose borrowings) to large-cap growth stocks.
Key data points to note: the fund’s expense ratio sits around 0.65%, positioning it competitively among actively managed growth ETFs; its top holdings typically include high-growth names in technology and consumer discretionary such as Apple, Microsoft, and Amazon, which together account for roughly 30% of assets; and its performance is closely tied to macro drivers like U.S. GDP growth, corporate earnings trends, and the Federal Reserve’s monetary policy stance, all of which influence the valuation environment for growth equities.
For a deeper dive into BAMG’s risk-adjusted returns and sector exposure, you might explore the analytics on ValueRay to see how the ETF stacks up against its peers.
What is the price of BAMG shares?
Over the past week, the price has changed by -1.42%, over one month by -4.07%, over three months by -0.33% and over the past year by +10.71%.
Is BAMG a buy, sell or hold?
What are the forecasts/targets for the BAMG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 42.7 | 9.6% |
BAMG Fundamental Data Overview February 05, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 129.3m USD (129.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 129.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 129.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.68% (E(129.3m)/V(129.3m) * Re(9.68%) + (debt-free company))
Discount Rate = 9.68% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)